Trial Profile
Clinical Trials Insight: 700057313
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2010
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- Sponsors PharmaMar
- 01 Jul 2010 New trial record